Test Price
2,800 AED✅ Home Collection Available
TBX3 Gene Ulnar-Mammary Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
This genetic test analyzes the entire coding region of the TBX3 gene using Next-Generation Sequencing (NGS) to diagnose Ulnar-Mammary Syndrome (ULMM) with 99.9% diagnostic sensitivity. The test is DHA licensed and ISO 9001:2015 certified. Priced at 2800 AED, the service includes pre- and post-test genetic counseling, temperature-controlled cold-chain home collection via VIP mobile phlebotomy, and telephonic clinical guidance for result interpretation. Direct billing verification is available via WhatsApp.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This genetic test examines the entire coding region of the TBX3 gene to confirm a diagnosis of Ulnar-Mammary Syndrome (ULMM) and assess hereditary cancer predisposition with 99.9% analytical sensitivity and specificity. The methodology employs Next-Generation Sequencing (NGS) augmented by MLPA analysis to detect large deletions or duplications that Sanger sequencing may miss.
| Feature | Our Test (NGS – DHA Licensed) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | >99.9% sensitivity & specificity for all TBX3 variants | ~95% for known point mutations; misses large rearrangements |
| Methodology | NGS with MLPA backup for del/dup | Sanger sequencing only |
| Turnaround Time | 3–4 Weeks (Urgent available) | 6–8 Weeks |
| Data Privacy | UAE PDPL & ISO 9001:2015 Compliant | Variable; often non-compliant |
Physician Insight & Safety Protocols
“A positive TBX3 result should always be correlated with the patient’s clinical phenotype and family pedigree before drawing prognostic conclusions. This test provides diagnostic clarity, not a verdict. I strongly recommend that all findings be discussed with a board-certified genetic counselor to establish a personalized surveillance and management plan tailored to the patient’s specific variant and family history.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory Protocol & Medication Safety
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace ongoing medical therapy or specialist evaluation.
Exclusion Criteria & Safety Red Flags
- Age Restriction: This test is not available for individuals under 18 years without legal guardian consent and full compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability regarding minors.
- ER Red Flags: If you experience excessive bleeding from the draw site, signs of infection (redness, warmth, pus), or fainting, seek emergency care immediately. This test does not replace acute medical evaluation.
- Data Privacy: All genetic data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Patient FAQ & Clinical Guidance
1. What does a positive TBX3 mutation result mean for my family?
A positive result confirms Ulnar-Mammary Syndrome and may indicate an elevated risk for breast and pancreatic cancer, which necessitates formal genetic counseling and a structured surveillance protocol for the patient and at-risk relatives.
2. How is the sample collected and is it painful?
A trained VIP mobile phlebotomist performs a standard venipuncture blood draw or a painless finger-prick onto an FTA collection card in the comfort of your home. Both methods are quick, minimally invasive, and conducted under strict cold-chain protocols to preserve nucleic acid integrity.
3. Will my insurance cover the cost of this test?
Many UAE health insurance providers reimburse genetic testing when deemed medically necessary by a referring physician. Contact our billing team via WhatsApp at +971 54 548 8731 to verify your direct billing eligibility and coverage details before booking.
4. How long does it take to receive results?
Standard turnaround time is 3 to 4 weeks from sample receipt at the laboratory. Urgent processing can be arranged upon request with your physician’s endorsement.
5. Can I get tested if I have no symptoms but a family history of ULMM?
Yes. Predictive testing for asymptomatic adult relatives with a known familial TBX3 mutation is clinically appropriate and recommended. Pre-test genetic counseling is mandatory to discuss implications of a positive or negative result.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
All genetic data generated through this test is processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety, patient consent, and medical liability adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | TBX3 Gene Sequencing for Ulnar-Mammary Syndrome (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks (21–28 calendar days); urgent expedite available upon request |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA tube) or FTA Card Finger-Prick; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) with MLPA backup for deletion/duplication detection |
| ICD-10-CM Code | Q87.2 (Congenital malformation syndromes predominantly involving limbs) |
| LOINC Code | 78941-3 (Gene mutations identified in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians